Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 607
Selected: 0
NCT IDTitle
NCT02186444Navigator Guided e-Psychoeducational Intervention
NCT06745882Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
NCT04598724Addressing Barriers to Palliative Care Use in Bladder Cancer
NCT06497569Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
NCT00042731Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy
NCT06511882Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
NCT02155088BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer
NCT00720096Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan
NCT01804179Colorectal Cancer Awareness, Research, Education and Screening (CARES)
NCT00101166Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma
NCT00504257Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
NCT05108428Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
NCT02313272Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
NCT02292173Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
NCT05004662Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
NCT00375024Patient Navigator Project
NCT03834623Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
NCT00977548Erlotinib Study for Myelodysplastic Syndrome (MDS)
NCT01253148Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
NCT01531205Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
NCT04596579SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
NCT01432574Study of Gardasil in Mid-Adult Males (MAM)
NCT03760523Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
NCT00786760Natural History of HPV Infection in Men: The HIM Study
NCT05687188Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
NCT00215943Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
NCT03543189Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
NCT00005615Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
NCT00005640Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer
NCT06860386Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
NCT05064423Clinical Trials Outreach & Education
NCT03605927CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease
NCT01659151Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
NCT00226590Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
NCT01048723Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas
NCT03337451Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
NCT01010854Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer
NCT01754623GTX-RT in Borderline Resectable Pancreatic Cancer
NCT01005745Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
NCT06963346Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
NCT00858403Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
NCT05694364Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
NCT00964743Depocyt® With Sorafenib in Neoplastic Meningitis
NCT04380441Quality of Life Model for Older Patients With AML
NCT07090174Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
NCT04191187Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT00598507Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
NCT04610671Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
NCT00005641Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT05704933Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases